Inhibiting Rev1-mediated DNA translesion synthesis for cancer therapy
Research Grant
Awarded By
National Cancer Institute
Start Date
January 1, 2024
End Date
November 30, 2028
Awarded By
National Cancer Institute
Start Date
January 1, 2024
End Date
November 30, 2028